Drugs / P-3073
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03079973 | May 2017 → Jul 2018 | psoriasis | Polichem S.A. | Withdrawn | No outcome recorded |
| Phase 3 | NCT02606760 | Nov 2015 → Feb 2017 | psoriasis | Polichem S.A. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | P-3073 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02606760 ↗ |
| Known as | calcipotriene | “Topical solution P-3073 (calcipotriene 0.005%) once daily for 24 weeks.” NCT03079973 ↗ |
| Route | Topical | “P-3073 for topical treatment of nail psoriasis” NCT02606760 ↗ |